Fisetin Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: 3,3',4',7-Tetrahydroxyflavone, 7,3',4'-Flavon-3-ol

Pipeline

Early 1: 1Phase 2: 2

Top Sponsors

Jonsson Comprehensive Cancer Center2
Mayo Clinic1

Indications

Cancer3
Anatomic Stage III Breast Cancer AJCC v82
Anatomic Stage II Breast Cancer AJCC v82
Breast Cancer2
Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v81

Alhambra, California2 trials

Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors

UCLA Health Cancer Care in Alhambra

Phase 2

Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors

UCLA Health Cancer Care in Alhambra

Phase 2

Rochester, Minnesota1 trial

Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or Temozolomide for the Treatment of Previously Treated Glioma With Residual Disease

Mayo Clinic in Rochester

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.